使用非肝素抗凝剂治疗ChAdOx1 nCoV-19疫苗接种相关疫苗诱导免疫性血栓性血小板减少症伴多发性静脉血栓病变的濒死病例
本文报告一例21岁女性在接种首剂ChAdOx1 nCoV-19疫苗数日后出现大脑深、浅静脉大面积血栓形成,伴癫痫发作、局灶性神经功能缺损和血小板减少。在神经重症监护室,尽管早期行去骨瓣减压术,病情仍恶化,出现双侧段性肺栓塞、左肝静脉和左髂外静脉血栓形成。入院第6天启动阿加曲班(0.5-2.2 µg/kg/min)和高剂量静脉免疫球蛋白(1 g/kg/d,连续2天)治疗,多部位静脉血栓逐渐消退,血小板计数恢复正常。患者离开ICU时神志完全清醒,表现为表达性失语和右侧偏瘫。
要点
- 21岁女性接种首剂ChAdOx1 nCoV-19疫苗数日后出现大脑深、浅静脉大面积血栓形成,伴癫痫发作、局灶性神经功能缺损和血小板减少。
- 在神经重症监护室,尽管早期行去骨瓣减压术,病情仍恶化,出现双侧段性肺栓塞、左肝静脉和左髂外静脉血栓形成。
- 入院第6天启动阿加曲班(0.5-2.2 µg/kg/min)和高剂量静脉免疫球蛋白(1 g/kg/d,连续2天)治疗。
- 治疗后多部位静脉血栓逐渐消退,血小板计数恢复正常。
- 患者离开ICU时神志完全清醒,表现为表达性失语和右侧偏瘫。
适用人群与场景
- 接种首剂ChAdOx1 nCoV-19疫苗数日后出现多发性静脉血栓形成、癫痫发作、局灶性神经功能缺损和血小板减少的21岁女性。
处置流程与药物剂量
- 入院第6天启动阿加曲班(0.5-2.2 µg/kg/min)和高剂量静脉免疫球蛋白(1 g/kg/d,连续2天)治疗。
- 在神经重症监护室行早期去骨瓣减压术。
研究设计与关键结果
- 病例报告:21岁女性接种首剂ChAdOx1 nCoV-19疫苗数日后出现大脑深、浅静脉大面积血栓形成,伴癫痫发作、局灶性神经功能缺损和血小板减少。
- 在神经重症监护室,尽管早期行去骨瓣减压术,病情仍恶化,出现双侧段性肺栓塞、左肝静脉和左髂外静脉血栓形成。
- 入院第6天启动阿加曲班(0.5-2.2 µg/kg/min)和高剂量静脉免疫球蛋白(1 g/kg/d,连续2天)治疗后,多部位静脉血栓逐渐消退,血小板计数恢复正常。
- 患者离开ICU时神志完全清醒,表现为表达性失语和右侧偏瘫。
证据类型、等级与局限
- 病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,即使存在多发性、危及生命的静脉血栓病变,疫苗诱导免疫性血栓性血小板减少症仍可获得良好结局。
- 作者认为,阿加曲班和高剂量静脉免疫球蛋白联合严重脑静脉血栓形成的管理在本例良好结局中发挥了主要作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe the successful recovery from multiple and life-threatening venous thrombosis after ChAdOx1 nCoV-19 vaccination.
DESIGN: Case report.
SETTING: University Hospital.
PATIENT: Few days after the first dose of the ChAdOx1 nCoV-19 vaccine, a 21-year-old woman experienced massive thrombosis in the deep and superficial cerebral veins together with seizures, neurologic focal deficit, and thrombocytopenia. In the neurointensive care unit, her condition worsened despite early decompressive craniectomy. She developed bilateral segmental pulmonary embolism, left hepatic, and left external iliac venous thrombosis.
INTERVENTION: Argatroban (0.5-2.2 µg/kg/min) and high-dose IV immunoglobulin (1 g/kg/d for 2 consecutive days) were initiated on day 6 after admission. With these therapies, there was a gradual resolution of multiple sites of venous thrombosis, and platelet count returned to normal. The patient left the ICU with full consciousness, expressive aphasia, and right hemiparesis.
CONCLUSIONS: This case of vaccine-induced immune thrombotic thrombocytopenia shows that a good outcome can be obtained even with multiple and life-threatening venous thrombotic lesions. Argatroban and high-dose IV immunoglobulin along with management of severe cerebral venous thrombosis played a major role in this epilogue.
参考来源
- Bersinger S, Lagarde K, Marlu R, et al. Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Crit Care Med. 2021. PMID: 34049307. doi:10.1097/CCM.0000000000005105
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。